Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8229489 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 10 Pages |
Abstract
Data were sufficient to support the use of HF-WBI for patients with early-stage breast cancer who met all the aforementioned criteria. For other patients, the task force could not reach agreement either for or against the use of HF-WBI, which nevertheless should not be interpreted as a contraindication to its use.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Benjamin D. M.D., Soren M. Ph.D., D.Sc., Candace R. M.D., Carol A. M.D., Patricia H. M.D., Geoffrey S. Ph.D., Beryl M.D., FACR., Julie R. CHES., RHEd., Lori J. M.D., Simon N. M.D., Ph.D., Abram M.D., Alphonse G. M.D., Ph.D., Frank A. M.D., FACR.,